Effective March 31, 2022, tramadol will be removed from the Prescription Drug List (PDL) and listed in Schedule 1 of the Controlled Drugs and Substances Act (CDSA). Tramadol will also be listed as item 19 in the Schedule of the Narcotic Control Regulations (NCR). This means that tramadol will be subject to all the regulatory requirements set out in the CDSA and NCR. The rational to change the listing is to reduce risks to human health, and to facilitate the detection and prevention of diversion of tramadol.
For a full explanation, including impact to practice, please visit:
https://gazette.gc.ca/rp-pr/p2/2021/2021-03-31/html/sor-dors43-eng.html
If you have any question about your NP practice, please contact practicadvice@crns.ca. If you have any questions about prescribing controlled drugs and substances or the CRNS
Prescription Review Program, please contact prp@crns.ca